Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mignon L Loh

Showing results (71-80 of 297) with videos related to

Pageof 30
Sort By:
Pediatric Blood & Cancer|November 2, 2017
Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology GroupRachel E Rau, ZoAnn Dreyer, Mi Rim Choi, et al.
Elife|July 24, 2013
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancyStefan Heinrichs, Lillian F Conover, Carlos E Bueso-Ramos, et al.
Cancer Science|April 12, 2019
Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemiaNitesh D Sharma, Christian K Nickl, Huining Kang, et al.
Nature Communications|December 21, 2017
Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemiaElliot Stieglitz, Tali Mazor, Adam B Olshen, et al.
Blood|April 21, 2017
Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemiaKarina A Kruth, Mimi Fang, Dawne N Shelton, et al.
Pediatric Blood & Cancer|June 29, 2019
Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemiaSaman K Hashmi, Jyotinder N Punia, Andrea N Marcogliese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2020
International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic LeukemiaMaximilian Schönung, Julia Meyer, Peter Nöllke, et al.
Blood Advances|January 4, 2018
Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALLKathryn G Roberts, Yung-Li Yang, Debbie Payne-Turner, et al.
Blood|June 12, 2012
Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemiaSarah K Tasian, Michelle Y Doral, Michael J Borowitz, et al.
Pediatric Blood & Cancer|August 8, 2023
Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1)Elizabeth A Raetz, David T Teachey, Charles Minard, et al.
Pageof 30

Showing results (71-80 of 297) with videos related to

Sort By:
Pageof 30
Pediatric Blood & Cancer|November 2, 2017
Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology GroupRachel E Rau, ZoAnn Dreyer, Mi Rim Choi, et al.
Elife|July 24, 2013
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancyStefan Heinrichs, Lillian F Conover, Carlos E Bueso-Ramos, et al.
Cancer Science|April 12, 2019
Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemiaNitesh D Sharma, Christian K Nickl, Huining Kang, et al.
Nature Communications|December 21, 2017
Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemiaElliot Stieglitz, Tali Mazor, Adam B Olshen, et al.
Blood|April 21, 2017
Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemiaKarina A Kruth, Mimi Fang, Dawne N Shelton, et al.
Pediatric Blood & Cancer|June 29, 2019
Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemiaSaman K Hashmi, Jyotinder N Punia, Andrea N Marcogliese, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2020
International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic LeukemiaMaximilian Schönung, Julia Meyer, Peter Nöllke, et al.
Blood Advances|January 4, 2018
Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALLKathryn G Roberts, Yung-Li Yang, Debbie Payne-Turner, et al.
Blood|June 12, 2012
Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemiaSarah K Tasian, Michelle Y Doral, Michael J Borowitz, et al.
Pediatric Blood & Cancer|August 8, 2023
Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1)Elizabeth A Raetz, David T Teachey, Charles Minard, et al.
Pageof 30